A pilot study comparing furosemide and hydrochlorothiazide in patients with hypertension and stage 4 or 5 chronic kidney disease

The Journal of Clinical Hypertension
Bertrand DussolYvon Berland

Abstract

Furosemide is the diuretic of choice for the treatment of hypertension in chronic kidney disease but the adaptative changes in the distal nephron may decrease its efficacy. Hydrochlorothiazide is not believed to be efficient in this setting. In a randomized, double-blind, cross-over trial, 23 patients with hypertension and stage 4 or 5 chronic kidney disease received long-acting furosemide (60 mg) and hydrochlorothiazide (25 mg) for 3 months and then both diuretics for 3 months. Sodium and chloride fractional excretions were measured after 3 months of each diuretic and then after their association. A trend towards an increase in the fractional excretion of sodium and chloride was observed with furosemide and hydrochlorothiazide (P=not significant). The association of the two diuretics increased the fractional excretions of sodium and chloride from 3.4±1.8 to 4.9±2.8 and from 3.8±2.0 to 6.0±3.1, respectively (P<.05). Furosemide and hydrochlorothiazide decreased mean blood pressure by the same extent. The association of the two diuretics was more efficient on blood pressure. There were no differences between furosemide and hydrochlorothiazide with respect to natriuresis and blood pressure control in patients with hypertension and...Continue Reading

Associated Clinical Trials

References

Dec 7, 1978·The New England Journal of Medicine·N S BrickerA Light
Oct 1, 1990·American Journal of Epidemiology·D P KielP W Wilson
Jan 1, 1984·European Journal of Clinical Pharmacology·D LoewH E Knoell
Jan 1, 1984·European Journal of Clinical Pharmacology·H Knauf, E Mutschler
Jan 1, 1994·European Journal of Clinical Pharmacology·H KnaufE Mutschler
Aug 1, 1997·Clinical Pharmacology and Therapeutics·J A FergusonD C Brater
Aug 6, 1998·The New England Journal of Medicine·D C Brater
Dec 24, 2004·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Bertrand DussolYvon Berland
Jun 28, 2005·Clinical and Experimental Nephrology·Misa TanakaTakahiko Ono

Citations

May 2, 2014·Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række·Lene HerambKnut Aasarød
Nov 25, 2014·Seminars in Nephrology·Ramapriya Sinnakirouchenan, Theodore A Kotchen
Sep 7, 2012·Journal of the American Society of Hypertension : JASH·Rajiv Agarwal, Arjun D Sinha
Mar 10, 2016·Current Hypertension Reports·Line Malha, Samuel J Mann
Mar 19, 2016·Journal of the American Society of Hypertension : JASH·Arjun D Sinha, Rajiv Agarwal
Mar 18, 2016·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Douglas L Blowey
Apr 14, 2016·Current Hypertension Reports·Martin J Wolley, Michael Stowasser
May 14, 2014·Clinical and Experimental Nephrology·Taro HoshinoKaoru Tabei
Mar 10, 2015·Current Hypertension Reports·Arjun D Sinha, Rajiv Agarwal
Feb 24, 2015·Advances in Chronic Kidney Disease·Eric Judd, David A Calhoun
Nov 5, 2015·Lancet·Patrick RossignolCardiovascular and Renal Clinical Trialists (F-CRIN INI-CRCT) network
Jun 22, 2016·Advances in Chronic Kidney Disease·Aziz Valika, Aldo J Peixoto
Jul 22, 2016·PloS One·Yusra Habib KhanTauqeer Hussain Mallhi
Feb 26, 2019·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Branko BraamAminu K Bello
Feb 15, 2014·American Journal of Nephrology·Rajiv AgarwalFarah Ammous
Nov 6, 2015·American Journal of Physiology. Renal Physiology·Simone Costa Alarcon AriasR Zatz
Jun 8, 2015·Current Opinion in Cardiology·Arjun D Sinha, Rajiv Agarwal
Feb 17, 2019·European Journal of Clinical Pharmacology·Toshinori HiraiToshimasa Itoh
Jan 31, 2020·Journal of the American Society of Nephrology : JASN·Dominique M BovéeEwout J Hoorn
Mar 9, 2017·Clinical and Experimental Nephrology·Yusra Habib KhanTauqeer Hussain Mallhi
Jan 11, 2021·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Elena Rodríguez-SánchezGema Ruiz-Hurtado
Jun 4, 2020·Current Opinion in Cardiology·Muhannad AlqudsiJuan Carlos Q Velez
Jan 15, 2021·Vascular Health and Risk Management·Erietta PolychronopoulouMichel Burnier

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Related Papers

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
Bertrand DussolYvon Berland
JAMA : the Journal of the American Medical Association
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatm
© 2021 Meta ULC. All rights reserved